Cilostazol attenuates MCP-1 and MMP-9 expression in vivo in LPS-administrated balloon-injured rabbit aorta and in vitro in LPS-treated monocytic THP-1 cells

Journal of Cellular Biochemistry

Volumn 103, Issue 1, 2008, Pages 54-66

  Tsai, Chien Sung ^a   Lin, Feng Yen ^b   Chen, Yung Hsiang ^c   Yang, Tung Lin ^a,d   Wang, Hsiao Jung ^e   Huang, Guo Shine ^a   Lin, Chih Yuan ^a   Tsai, Yi Tin ^a   Lin, Shing Jong ^e   Li, Chi Yuan ^a,f  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Cilostazol; Inflammation; Lipopolysaccharide; Matrix metalloproteinase; Monocyte chemoattractant protein 1; Phosphodiesterase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BUCLADESINE; CILOSTAZOL; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL INFILTRATION; CONTROLLED STUDY; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; AORTA; BALLOON DILATATION; CELL LINE; CHEMOKINE CCL2; CHEMOTAXIS; CYCLIC AMP; CYTOPROTECTION; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MALE; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; NF-KAPPA B; RABBITS; TETRAZOLES; TRANSCRIPTION FACTOR AP-1;

ORYCTOLAGUS CUNICULUS;

EID: 38149067309     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21388     Document Type: Article

References (38)

1. Abusamieh M, Ash J. 2004. Atherosclerosis and systemic lupus erythematosus. Cardiol Rev 12:267-275.
2. Aukrust P, Berge RK, Ueland T, Aaser E, Damas JK, Wikeby L, Brunsvig A, Muller F, Forfang K, Froland SS, Gullestad L. 2001. Interaction between chemokines and oxidative stress: Possible pathogenic role in acute coronary syndromes. J Am Coll Cardiol 37:485-491.
3. Chait A, Han CY, Oram JF, Heinecke JW. 2005. Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: Markers or mediators of cardiovascular disease? J Lipid Res 46:389-403.
4. Danenberg HD, Welt FG, Walker M 3rd, Seifert P, Toegel GS, Edelman ER. 2002. Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation 105:2917-2922.
5. Dawson DL, Cutler BS, Meissner MH, Strandness DE Jr. 1998. Cilostazol has beneficial effects in treatment of intermittent claudication: Results from a multicenter, randomized, prospective, double-blind trial. Circulation 98:678-686.
6. Douglas JS Jr, Holmes DR Jr, Kereiakes DJ, Grines CL, Block E, Ghazzal ZM, Morris DC, Liberman H, Parker K, Jurkovitz C, Murrah N, Foster J, Hyde P, Mancini GB, Weintraub WS. 2005. Coronary stent restenosis in patients treated with cilostazol. Circulation 112:2826-2832.
7. Fujinaga K, Onoda K, Yamamoto K, Imanaka-Yoshida K, Takao M, Shimono T, Shimpo H, Yoshida T, Yada I. 2004. Locally applied cilostazol suppresses neointimal hyperplasia by inhibiting tenascin-C synthesis and smooth muscle cell proliferation in free artery grafts. J Thorac Cardiovasc Surg 128:357-363.
8. Gadella TW Jr, Jovin TM. 1995. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation. J Cell Biol 129:1543-1558.
9. Gerszten RE, Mach F, Sauty A, Rosenzweig A, Luster AD. 2000. Chemokines, leukocytes, and atherosclerosis. J Lab Clin Med 136:87-92.
10. Goetzl EJ, Banda MJ, Leppert D. 1996. Matrix metalloproteinases in immunity. J Immunol 156:1-4.
11. Husid MS. 2004. New onset migraine with aura following head injury: A case report. Headache 44:1048-1050.
12. Iwamoto M, Osajima A, Tamura M, Suda T, Ota T, Kanegae K, Watanabe Y, Kabashima N, Anai H, Nakashima Y. 2003. Adrenomedullin inhibits pressure-induced mesangial MCP-1 expression through activation of protein kinase A. J Nephrol 16:673-681.
13. Kariyazono H, Nakamura K, Shinkawa T, Yamaguchi T, Sakata R, Yamada K. 2001. Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol. Thromb Res 101:445-453.
14. Kayanoki Y, Che W, Kawata S, Matsuzawa Y, Higashiyama S, Taniguchi N. 1997. The effect of cilostazol, a cyclic nucleotide phosphodiesterase III inhibitor, on heparin-binding EGF-like growth factor expression in macrophages and vascular smooth muscle cells. Biochem Biophys Res Commun 238:478-781.
15. Kim KY, Shin HK, Choi JM, Hong KW. 2002. Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells. J Pharmacol Exp Ther 300:709-715.
16. Kondo S, Kubota S, Shimo T, Nishida T, Yosimichi G, Eguchi T, Sugahara T, Takigawa M. 2002. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 23:769-776.
17. Lee JH, Oh GT, Park SY, Choi JH, Park JG, Kim CD, Lee WS, Rhim BY, Shin YW, Hong KW. 2005. Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol. J Pharmacol Exp Ther 313:502-509.
18. Lin SJ, Yang TH, Chen YH, Chen JW, Kwok CF, Shiao MS, Chen YL. 2002. Effects of Ginkgo biloba extract on the proliferation of vascular smooth muscle cells in vitro and on intimal thickening and interleukin-1beta expression after balloon injury in cholesterol-fed rabbits in vivo. J Cell Biochem 85:572-582.
19. Lin SJ, Shyue SK, Hung YY, Chen YH, Ku HH, Chen JW, Tam KB, Chen YL. 2005. Superoxide dismutase inhibits the expression of vascular cell adhesion molecule-1 and intracellular cell adhesion molecule-1 induced by tumor necrosis factor-alpha in human endothelial cells through the JNK/p38 pathways. Arterioscler Thromb Vasc Biol 25:334-340.
20. Matousovic K, Grande JP, Chini CC, Chini EN, Dousa TP. 1995. Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells. J Clin Invest 96:401-410.
21. Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, Matsushima K, Sasayama S. 1997. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 29:419-423.
22. Matsumoto T, Kobayashi T, Wakabayashi K, Kamata K. 2005. Cilostazol improves endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from diabetic rats. Am J Physiol Heart Circ Physiol 289:1933-1940.
23. Nieto FJ. 1998. Infections and atherosclerosis: New clues from an old hypothesis? Am J Epidemiol 148:937-948.
24. Nishio Y, Kashiwagi A, Takahara N, Hidaka H, Kikkawa R. 1997. Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells. Horm Metab Res 29:491-495.
25. Oger S, Mehats C, Dallot E, Cabrol D, Leroy MJ. 2005. Evidence for a role of phosphodiesterase 4 in lipopolysaccharide-stimulated prostaglandin E2 production and matrix metalloproteinase-9 activity in human amniochorionic membranes. J Immunol 174:8082-8089.
26. Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW. 2001. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: An autoradiographic study. Circulation 104:203-208.
27. Park SY, Lee JH, Kim YK, Kim CD, Rhim BY, Lee WS, Hong KW. 2005. Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation. J Pharmacol Exp Ther 312:1241-1248.
28. Pauletto P, Sartore S, Pessina AC. 1994. Smooth-muscle-cell proliferation and differentiation in neointima formation and vascular restenosis. Clin Sci (Lond) 87:467-479.
29. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, Lopez-Anaya A, McClure KF, Mitchell PG, Libby P, Lee RT. 1999. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 99:3063-3070.
30. Rollins BJ, Walz A, Baggiolini M. 1991. Recombinant human MCP-1/JE induces Chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78:1112-1116.
31. Santibanez JF, Olivares D, Guerrero J, Martinez J. 2003. Cyclic AMP inhibits TGFbeta1-induced cell-scattering and invasiveness in murine-transformed keratinocytes. Int J Cancer 107:715-720.
32. Thomas MK, Francis SH, Corbin JD. 1990. Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. J Biol Chem 265:14964-14970.
33. Tomita T, Nakase T, Kaneko M, Shi K, Takahi K, Ochi T, Yoshikawa H. 2002. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 46:373-378.
34. Woo SK, Kang WK, Kwon KI. 2002. Pharmacokinetic and pharmacodynamic modeling of the antiplatelet and cardiovascular effects of cilostazol in healthy humans. Clin Pharmacol Ther 71:246-252.
35. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Demedts MG, Verleden GM. 2003. Modulation by cAMP of IL-1beta-induced eotaxin and MCP-1 expression and release in human airway smooth muscle cells. Eur Respir J 22:220-226.
36. Yassen KA, Galley HF, Webster NR. 2001. Matrix metalloproteinase-9 concentrations in critically ill patients. Anaesthesia 56:729-732.
37. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D. 1991. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88:5252-5256.
38. Yoshimura T, Takeya M, Takahashi K. 1991. Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines. Biochem Biophys Res Commun 174:504-509.